From wound to scar

Burns

Volumn 22, Issue 5, 1996, Pages 339-352

  Linares, Hugo A ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BURN; HEMOSTASIS; HUMAN; KELOID; REVIEW; SCAR FORMATION; WOUND HEALING;

EID: 0030222207     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/0305-4179(95)00164-6     Document Type: Article

References (122)

1. 1 Gamelli RL. Wound healing. In: Gamelli RL, Dries DJ, eds. Trauma 2000. Austin: RG Landes, 1992; pp 139-145.
2. 2 Dover R, Wright NA. The cell proliferation kinetics of the epidermis. In: Goldsmith LA (ed) Physiology, Biochemistry, and Molecular Biology of the Skin, New York: Oxford University Press, 1991; pp 239-265.
3. 3 Larson DL, Abston S, Dobrkovsky M et al. The Prevention and Correction of Burn Scar Contracture and Hypertrophy. Galveston: Shriners Burns Institute, 1973; pp 1-21.
4. 4 Kloth LC, Miller KH. The inflammatory response to wounding. In: Kloth LC, McCulloch JM, Feedar JA (eds) Wound Healing: alternatives in management, Philadelphia: FA Davis, 1990; pp 3-13.
5. 5 Shattil SJ, Bennett JS. Platelets and their membranes in hemostasis: physiology and pathophysiology. Ann Intern Med 1980; 94: 108-116.
6. 6 Cotran RS, Kumar V, Robbins SL eds. Pathologic Basis of Disease, 5th edn. Philadelphia: WB Saunders, 1994.
7. 7 Davidson JM. Wound repair. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. New York: Raven Press, 1992; pp 809-819.
8. 8 Goslen JB. Wound healing for the dermatologic surgeon. J Dermatol Surg Oncol 1988; 9: 959-972.
9. 9 Barbul A. Immune aspects of wound repair. Clin Plast Surg 1990; 17: 433-442.
10. 10 Efron JE, Frankel HL, Lazarou SA, Wasserkrug HL, Barbul A. Wound healing and T-lymphocytes. J Surg Res 1990; 48: 460-463.
11. 11 Regan MC, Barbul A. Immune control of wound healing. In: Gamelli RL, Dries DJ, eds. Trauma 2000. Austin: RG Landes, 1992; pp 146-150.
12. 12 Trabucchi E, Radaelli E, Marazzi M et al. The role of mast cells in wound healing. Int J Tiss Reac 1988; 6: 367-371.
13. 13 Diegelmann RF, Cohen IK, Kaplan AM. The role of macrophages in wound repair: a review. Plast Reconstr Surg 1981; 7: 107-113.
14. 14 Browder W, Williams D, Lucore P, Pretus H, Jones E, McNamee R. Effect of enhanced macrophage function on early wound healing. Surgery 1988; 104: 224-230.
15. 15 Eckersley JRT, Dudley HAF. Wounds and wound healing. Br Med Bull 1988; 44: 423-436.
16. 16 Lambert WC, Cohen PJ, Klein KM, Lambert MW. Cellular and molecular mechanisms in wound healing: selected concepts. Clin Dermatol 1984; 2: 17-23.
17. 17 Hunt TK. Physiology of wound healing. In: Clowes GHA ed. Trauma, Sepsis and Shock, New York: Marcel Dekker, 1988; pp 443-471.
18. 18 Gabbiani G, Ryan GD, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27: 549-553.
19. 19 Banda MJ, Herron GS, Murphy G, Werb Z, Dwyer KS. Proteinase induction by endothelial cells during wound repair. In: Barbul A. Pines E, Caldwell M, Hung TK (eds) Growth Factors and Other Aspects of Wound Healing: biological and clinical implications. New York: Alan R Liss, 1988; pp 117-130.
20. 20 Folkman J, Brem H. Angiogenesis and inflammation. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. New York: Raven Press, 1992; pp 821-839.
21. 21 Schoefl GI. Studies of inflammation. III. Growing capillaries: their structure and permeability. Virchows Arch Pathol Anat 1963; 337: 97-101.
22. 22 Claudy AL. Les Collagenes. Ann Dermatol Venereol 1988; 115: 767-771.
23. 23 Hopkinson I. The extracellular matrix in wound healing: collagen in wound healing. Wounds 1992; 4: 124-132.
24. 24 McPherson JM, Piez KA. Collagen in dermal wound repair. In: Clark RAF, Henson PM (eds) The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1988; pp 471-496.
25. 25 Engel J. Common structural motifs in proteins of the extracellular matrix. Curr Opin Cell Biol 1991; 779-785.
26. 26 Chiquet-Ehrismann R. Anti-adhesive molecules of the extracellular matrix. Cur Opin Cell Biol 1991; 3: 800-804.
27. 27 Pignatelli M, Vessey CJ. Adhesion molecules: novel molecular tools in tumor pathology. Human Pathol 1994; 25: 849-856.
28. 28 Ruoslahti E. Proteoglycans in cell regulation. J Biol Chem 1989; 264: 13369-13372.
29. 29 Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991; 60: 443-475.
30. 30 Templeton DM. Proteoglycans in cell regulation. Crit Rev Clin Lab Sci 1992; 29: 141-184.
31. 31 Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB 1992; 6: 861-870.
32. 32 Ehrlich HP. Wound closure: evidence of cooperation between fibroblasts and collagen matrix. Eye 1988; 2: 149-157.
33. 33 Stenn KS, Malhotra R. Epithelialization. In: Cohen IK, Diegelmann RF, Lindblad WJ (eds) Wound Healing. Philadelphia: Saunders, 1992; pp 115-127.
34. 34 Goslen JB. Wound healing for the dermatologic surgeon. J Dermatol Surg Oncol 1988; 14: 959-972.
35. 35 Daly TJ. The repair phase of wound healing - re-epithelialization and contraction. In: Kloth LC, McCulloch JM, Feedar JA, eds. Wound Healing: alternatives in management, Philadelphia: FA Davis, 1990; pp 14-30.
36. 36 Krawczyk WS. The pattern of epidermal cell migration during wound healing. J Cell Biol 1971; 49: 247-263.
37. 37 Grinnell F. Fibronectin and wound healing. Am J Dermatopathol 1982; 4: 185-188.
38. 38 Winter GD. Formation of the scar and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-294.
39. 39 Hinman CD, Maibach H. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963; 200: 377-378.
40. 40 Eisenmenger W, Nerlich A, Gluck G. Die Bedeutung des Kollagens bei der Wundaltersbestunnbg. Z Rechtsmed 1988; 100: 79-100.
41. 41 Forrest L. Current concepts in soft connective tissue wound healing. Br J Surg 1983; 70: 133-140.
42. 42 Weingarten MS. Obstacles to wound healing. Wounds 1993; 5: 238-244.
43. 43 Seiler WO, Stahelin HB. Identification of factors that impair wound healing: a possible approach to wound healing research. Wounds 1994; 6: 101-106.
44. 44 Barbul A, Breslin RJ, Woodyard JP, Wasserkrug HL, Efron G. The effect of in vitro T helper and T suppressor lymphocyte depletion on wound healing. Ann Surg 1989; 209: 479-483.
45. 45 Barbul A. Role of T cell-dependent immune system in wound healing. In: Barbul A, Pines E, Caldwell M, Hunt TK (eds) Growth Factors and Other Aspects of Wound Healing: biological and clinical implications. New York: Alan R Liss, 1988; pp 161-175.
46. 46 Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17-23.
47. 47 Brotchie H, Wakefield D. Fibronectin: structure, function and significance in wound healing. Austr J Dermatol 1990; 31: 47-56.
48. 48 Postlethwaite AE, Kang AH. Fibroblast chemoattractants. Meth Enzymol 1988; 163: 694-707.
49. 49 Grotendorst GR. Chemoattractants and growth factors in wound healing. In: Cohen IK, Diegelmann RF, Lindblad WJ (eds) Wound Healing. Philadelphia: WB Saunders, 1992; pp 237-240.
50. 50 Grierson I, Joseph J, Miller M, Day JE. Wound repair: the fibroblast and the inhibition of scar formation. Eye 1988; 2: 135-148.
51. 51 Topol BW, Lewis VL, Benveniste K. The use of antihistamine to retard the growth of fibroblasts derived from human skin scar and keloid. Plast Reconstr Surg 1981; 68: 227-232.
52. 52 Urban RC, Kaufman LM. Mitomycin in the treatment of hypertrophic conjunctival scars after strabismus surgery. J Pediatr Ophthalmol Strabismus 1994; 31: 96-98.
53. 53 Madden JW, Morton D, Peacock EE. Contraction of experimental wounds. I. Inhibiting wound contraction by using a topical smooth muscle antagonist. Surgery 1974; 76: 8-15.
54. 54 Erlich HP, Grislis G, Hunt TK. Evidence for the involvement of microtubules in wound contraction. Am J Surg 1977; 133: 706-709.
55. 55 Erlich HP, Rajaratnam JBM, Griswold TR. ATP-induced cell contraction in dermal fibroblasts: effect of cAMP and myosin light-chain kinase. J Cell Physiol 1986; 128: 223-230.
56. 56 Orgill D, Demling RH. Current concepts and approaches to wound healing. Crit Care Med 1988; 9: 899-908.
57. 57 Hansbrough JF. Biologic mediators in wound healing. In: Hansbrough JF (ed) Wound Coverage, With Biologic Dressings and Cultured Skin Substitutes. Austin: RG Landes, 1992; pp 115-147.
58. 58 Uitto J, Olsen DR, Fazio MJ. Extracellular matrix of the skin: 50 years of progress. J Invest Dermatol 1989; 92: 61S-77S.
59. 59 Murray JC. Keloids and hypertrophic scars. Clin Dermatol 1994; 12: 27-37.
60. 60 Peacock EE. Control of wound healing and scar formation in surgical patients. Arch Surg 1981; 116: 1375-1379.
61. 61 Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg 1991; 27: 164-178.
62. 62 Granstein RD, Rook A, Flotte TJ et al. A controlled trial of intralesional recombinant interferon-γ in the treatment of keloidal scarring. Arch Dermatol 1990; 126: 1295-1302.
63. 63 Porras-Reyes BH, Mustoe TA. Wound healing. In: Cohen M (ed) Mastery of Plastic and Reconstructive Surgery, Boston: Little, Brown and Company, 1994; pp 3-13.
64. 64 Adolph VR, DiSanto SK, Bleacher JC, Dillon RW, Krummel TM. The potential role of lymphocyte in fetal wound healing. J Pediatr Surg 1993; 128: 1316-1320.
65. 65 Shah M, Foreman DM, Ferguson MWJ. Control of scarring in adult wounds by neutralising antibody to transforming growth factor. Lancet 1992; 339: 213-214.
66. 66 Beck S, DeGuzman L, Lee WP, Xu Y, Siegel MW, Amento EP. One systemic administration of TGF-β-1 reverses age or glucocorticoid impaired wound healing. J Clin Invest 1993; 92: 2841-2849.
67. 67 Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing; single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989; 84: 640-646.
68. 68 Herndon DN, Barrow RE, Kunkel KE, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg 1990; 212: 424-431.
69. 69 Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994; 220: 19-24.
70. 70 Ding M, Burstein NL. Review: fibronectin in corneal wound healing. J Ocular Pharm 1988; 4: 75-91.
71. 71 Woodley DT, O'Keefe EJ, Prunieras M. Cutaneous wound healing: a model for cell-matrix interactions. J Am Acad Dermatol 1985; 12: 420-433.
72. 72 Flanga M. Growth factors and wound healing. Wound Healing 1993; 11: 667-675.
73. 73 Dostal GH, Gamelli RH. Fetal wound healing. Surg Gynecol Obstet 1993; 176: 299-306.
74. 74 Adzick NS, Lorenz HP. Cells, matrix, growth factors and the surgeon. Ann Surg 1994; 220: 10-18.
75. 75 Adzick NS, Longaker MT. Scarless fetal healing: therapeutic implications. In: Adzick NS, Longaker ME (eds) Fetal Wound Healing. New York: Elsevier Scientific Press, 1992; pp 317-323.
76. 76 Lorenz HP, Whitby DJ, Longaker MT, Adzick NS. Fetal wound healing: the ontogeny of scar formation in the non-human primate. Ann Surg 1993; 217: 391-396.
77. 77 Krasner D (ed). Chronic Wound Care. Pennsylvania: Health Management Public, 1990.
78. 78 Linares HA, Kischer CW, Dobrkovsky M, Larson DL. The histiotypic organization of the hypertrophic scar in human. J Invest Dermatol 1972; 59: 323-331.
79. 79 Linares HA, Kischer CW, Dobrkovsky M, Larson DL. On the origin of the hypertrophic scar. J Trauma 1973; 13: 70-75.
80. 80 Linares HA, Larson DL. Early differential diagnosis between hypertrophic and nonhypertrophic healing. J Invest Dermatol 1974; 62: 514-516.
81. 81 Linares HA, Larson DL. Proteoglycans and collagenase in hypertrophic scar formation. J Plast Reconstr Surg 1978; 62: 589-593.
82. 82 Linares HA. Hypertrophic healing: controversies and etiopathogenic review in burns in children. In: Carvajal HF, Parks DH (eds) Burns in Children. Chicago: Year Book Medical, 1988; pp 305-323.
83. 83 Shetlar MR, Shetlar CL, Linares HA. The hypertrophic scar: location of glycosaminoglycans within scars. Burns 1977; 4: 14-19.
84. 84 Cohen IK, Keiser HR, Sjoerdsma A. Collagen synthesis in human keloid and hypertrophic scar. Surg Forum 1971; 22: 488-489.
85. 85 Craig RDP, Schofield JD, Jackson SS. Collagen biosynthesis in normal human skin, normal and hypertrophic scar and keloid. Eur J Clin Invest 1975; 5: 69-74.
86. 86 McCoy BJ, Cohen IK. Collagenase in keloid biopsies and fibroblasts. Connect Tissue Res 1982; 9: 181-192.
87. 87 Knapp TR, Daniels RJ, Kaplan EN. Pathologic scar formation. Am J Pathol 1977; 86: 47-67.
88. 88 Harris ED Jr, Sjoerdsma A. Collagen profile in various clinical conditions. Lancet 1966; ii: 707-719.
89. 89 Di Cessare PE, Cheung DT, Perelman N, Libaw E, Peng L, Nimni ME. Alteration of collagen composition and cross linking in keloid tissues. Matrix 1990; 10: 172-178.
90. 90 Cohen IK, Beaven MA, Horakova Z, Keiser HR. Histamine and collagen synthesis in keloid and hypertrophic scar. Surg Forum 1972; 23: 509.
91. 91 Abergel RP, Pizzurro D, Meeker CA et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985; 84: 384-390.
92. 92 Bailey AJ, Bazin S, Sims TJ, Lelous M, Nicoletis C, Delaunay A. Characterization of the collagen of human hypertrophic and normal scars. Biochim Biophys Acta 1975; 405: 412-421.
93. 93 Weber L, Meigel WN, Spier W. Collagen polymorphism in pathologic human scars. Arch Dermatol Res 1978; 261: 63-71.
94. 94 Abergel RP, Chu ML, Bauer EA, Uitto J. Regulation of collagen gene expression in cutaneous diseases with dermal fibrosis: evidence for pretranslational control. J Invest Dermatol 1987; 88: 727-731.
95. 95 Ala-Kokko L, Rintala A, Savolainen ER. Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 1987; 89: 238-244.
96. 96 Diegelmann RF, Cohen IK, McCoy BJ. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J Cell Physiol 1979; 98: 341-346.
97. 97 Craig RDP, Schofield JD, Jackson DS. Collagen biosynthesis in normal and hypertrophic scars and keloid as a function of the duration of the scar. Br J Surg 1975; 62: 741-744.
98. 98 Yeo TK, Brown L, Dvorak HF. Alterations in proteoglycan synthesis common to healing wound and tumors. Am J Pathol 1991; 138: 1437-1450.
99. 99 Shetlar MR, Dobrkovsky, Linares H, Villarante R, Shetlar CL, Larson DL. The hypertrophic scar. Glycoprotein and collagen components of burn scars. Soc Exp Biol Med 1971; 138: 298-300.
100. 100 Shetlar MR, Shetlar CL, Linares HA. The hypertrophic scars: location of glycoasminoglycans within scars. Burns 1977; 4: 14-19.
101. 101 Linares HA. Measurement of collagen proteoglycans interaction in hypertrophic scars. Plast Reconstr Surg 1983; 71: 818-819.
102. 102 Linares HA. Proteoglycan-lymphocyte association in the development of hypertrophic scars. Burns 1990; 16: 21-24.
103. 103 Savage K, Swann DA. A comparison of glycosaminoglycan synthesis by human fibroblasts from normal skin, normal scar, and hypertrophic scar. J Invest Dermatol 1985; 84: 521-526.
104. 104 Chytilova M, Kulhankek V, Horn V. Experimental production of keloids after immunization with autologous skin. Acta Chir Plast 1959; 1: 72-79.
105. 105 Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Molec Cell Biol 1989; 9: 1642-1650.
106. 106 Kischer CW, Hendrix MJC. Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res 1983; 231: 9-37.
107. 107 McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC. Altered cytokine production in black patients with keloids. J Clin Immunol 1992; 12: 300-308.
108. 108 Davidson JM, Broadley KN, Benn SI. Cytokine influences on ECM metabolism during wound healing. J Cell Biol 1993; S17E: 109.
109. 109 Sporn MB, Roberts AB. Introduction: what is TGF-β in clinical applications of TGF-beta. In: Ciba Foundation Symposium 157. Chichester: Wiley, 1991; pp 1-6.
110. 110 Babu M, Diegelmann R, Oliver N. Keloid fibroblasts exhibit and altered response to TGF-β. J Invest Dermatol 1992; 99: 650-655.
111. 111 Martin P, Hopkinson-Woolley J, McCluskey J. Growth factors and cutaneous wound repair. Prog Growth Factor Res 1992; 4: 25-44.
112. 112 Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg 1991; 27: 164-178.
113. 113 Linares HA, Larson DL, Willis-Galstaun BA. Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. Burns 1993; 19: 17-21.
114. 114 Larson DL, Evans EB, Abston S, Dobrkovsky M, Linares HA. Techniques for decreasing scar formation and scar contractures in the burn patient. J Trauma 1971; 11: 807-823.
115. 115 Linares HA, Larson DL, Baur PS. Influence of mechanical forces on burn scar contracture and hypertrophic. In: Krizek THJ, Hoopes JE (eds) Symposium on Basic Science in Plastic Surgery. St Louis: CV Mosby, 1976; pp 101-127.
116. 116 Larson DL, Huang TT, Linares HA, Dobrkovsky M, Baur PS, Parks DH. Prevention and treatment of scar contractures. In: Artz CP, Moncrief JA, Pruitt B (eds) Burns, A Team Approach Philadelphia: WB Saunders, 1979; pp 466-491.
117. 117 Alibert JLM. Description des maladies de le peau observees a l'hospital Saint-Louis et exposition des meilleurs methodes suives pour leur traitement. Pairs: Barrois l'Aine et Fils, 1806; p 113.
118. 118 Kaposi M. Connective tissue growths. In: Hebra F, Kaposi M (eds). Diseases of the Skin including the Exanthemata. London: The New Sydenham Society, 1874; pp 273-324.
119. 119 Blackburn WR, Cosman B. Histologic basis of keloid and hypertrophic scar differentiation. Arch Pathol 1966; 82: 65-71.
120. 120 Fries KM, Blieden T, Looney RJ et al. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopath 1994; 72: 283-294.
121. 121 Ko SD, Page RC, Narayanan AS. Fibroblast heterogeneity and prostaglandin regulation of subpopulations. Proc Natl Acad Sci USA 1977; 74: 3429-3432.
122. 122 Mollenhaver J, Bayreuther K. Donor-age-related changes in the morphology, growth potential, and collagen biosynthesis in rat fibroblast subpopulations in vitro. Differentiation 1986; 32: 165-172.